Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Roddy, Walsh"'
Autor:
Katherine S. Josephs, Angharad M. Roberts, Pantazis Theotokis, Roddy Walsh, Philip J. Ostrowski, Matthew Edwards, Andrew Fleming, Courtney Thaxton, Jason D. Roberts, Melanie Care, Wojciech Zareba, Arnon Adler, Amy C. Sturm, Rafik Tadros, Valeria Novelli, Emma Owens, Lucas Bronicki, Olga Jarinova, Bert Callewaert, Stacey Peters, Tom Lumbers, Elizabeth Jordan, Babken Asatryan, Neesha Krishnan, Ray E. Hershberger, C. Anwar A. Chahal, Andrew P. Landstrom, Cynthia James, Elizabeth M. McNally, Daniel P. Judge, Peter van Tintelen, Arthur Wilde, Michael Gollob, Jodie Ingles, James S. Ware
Publikováno v:
Genome Medicine, Vol 15, Iss 1, Pp 1-15 (2023)
Abstract Background As the availability of genomic testing grows, variant interpretation will increasingly be performed by genomic generalists, rather than domain-specific experts. Demand is rising for laboratories to accurately classify variants in
Externí odkaz:
https://doaj.org/article/b19fec6981b54abc9f8f6edd48178160
Autor:
Amber Waddell, Sophie Hespe, Babken Asatryan, Emma Owens, Courtney Thaxton, Mhy-Lanie Adduru, Kailyn Anderson, Emily Brown, Lily Hoffman-Andrews, Elizabeth Jordan, Megan Mayers, Stacey Peters, Fergus Stafford, Richard Bagnall, Lucas Bronicki, Bert Callewaert, C. Anwar Chahal, Cynthia James, Olga Jarinova, Andrew Landstrom, Elizabeth McNally, Brittney Murray, Laura Muiño-Mosquera, Victoria Parikh, Chloe Reuter, Roddy Walsh, Bess Wayburn, James Ware, Jodie Ingles
Publikováno v:
Genetics in Medicine Open, Vol 2, Iss , Pp 101047- (2024)
Externí odkaz:
https://doaj.org/article/bd0ce983443640bf8524d486c2542311
Publikováno v:
Physiological reviews. 103(3):2039-2055
Genome-wide association studies (GWAS) aim to identify common genetic variants that are associated with traits and diseases. Since 2005, more than 5,000 GWAS have been published for almost as many traits. These studies have offered insights into the
Autor:
Roddy Walsh, Francesco Mazzarotto, Nicola Whiffin, Rachel Buchan, William Midwinter, Alicja Wilk, Nicholas Li, Leanne Felkin, Nathan Ingold, Risha Govind, Mian Ahmad, Erica Mazaika, Mona Allouba, Xiaolei Zhang, Antonio de Marvao, Sharlene M. Day, Euan Ashley, Steven D. Colan, Michelle Michels, Alexandre C. Pereira, Daniel Jacoby, Carolyn Y. Ho, Kate L. Thomson, Hugh Watkins, Paul J. R. Barton, Iacopo Olivotto, Stuart A. Cook, James S. Ware
Publikováno v:
Genome Medicine, Vol 11, Iss 1, Pp 1-18 (2019)
Abstract Background International guidelines for variant interpretation in Mendelian disease set stringent criteria to report a variant as (likely) pathogenic, prioritising control of false-positive rate over test sensitivity and diagnostic yield. Ge
Externí odkaz:
https://doaj.org/article/dff8a2d61caa43d29ddbbb7e3f495ffe
Autor:
Francesco Mazzarotto, Iacopo Olivotto, Beatrice Boschi, Francesca Girolami, Corrado Poggesi, Paul J. R. Barton, Roddy Walsh
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 8 (2020)
Abstract Genetic testing for hypertrophic cardiomyopathy (HCM) is an established clinical technique, supported by 30 years of research into its genetic etiology. Although pathogenic variants are often detected in patients and used to identify at‐ri
Externí odkaz:
https://doaj.org/article/b884d942541041a89eac8d3be5f77b5f
Autor:
Heba Sh. Kassem, Roddy Walsh, Paul J. Barton, Besra S. Abdelghany, Remon S. Azer, Rachel Buchan, Shibu John, Ahmed Elguindy, Sarah Moharem-ElGamal, Hala M. Badran, Hoda Shehata, Stuart A. Cook, Magdi H. Yacoub
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 18, Iss 4, Pp 381-387 (2017)
Background: NGS enables simultaneous sequencing of large numbers of associated genes in genetic heterogeneous disorders, in a more rapid and cost-effective manner than traditional technologies. However there have been limited direct comparisons betwe
Externí odkaz:
https://doaj.org/article/0c6f1fead1724d898d4dc8c69c82896f
Autor:
Katherine S Josephs, Angharad M Roberts, Pantazis Theotokis, Roddy Walsh, Philip J Ostrowski, Matthew Edwards, Andrew Fleming, Courtney Thaxton, Jason D Roberts, Melanie Care, Wojciech Zareba, Arnon Adler, Amy C Sturm, Rafik Tadros, Valeria Novelli, Emma Owens, Lucas Bronicki, Olga Jarinova, Bert Callewaert, Stacey Peters, Tom Lumbers, Elizabeth Jordan, Babken Asatryan, Neesha Krishnan, Ray E Hershberger, C. Anwar A. Chahal, Andrew P. Landstrom, Cynthia James, Elizabeth M McNally, Daniel P Judge, Peter van Tintelen, Arthur Wilde, Michael Gollob, Jodie Ingles, James S Ware
BackgroundAs availability of genomic testing grows, variant interpretation will increasingly be performed by genomic generalists, rather than domain-specific experts. Demand is rising for laboratories to accurately classify variants in inherited card
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::502d4033679b4a938e71105a442ecd3f
https://doi.org/10.1101/2023.04.03.23287612
https://doi.org/10.1101/2023.04.03.23287612
Publikováno v:
Circulation. 145(12):892-895
Autor:
Rudolf A. de Boer, Stephane Heymans, Johannes Backs, Lucie Carrier, Andrew J.S. Coats, Stefanie Dimmeler, Thomas Eschenhagen, Gerasimos Filippatos, Lior Gepstein, Jean‐Sebastien Hulot, Ralph Knöll, Christian Kupatt, Wolfgang A. Linke, Christine E. Seidman, C. Gabriele Tocchetti, Jolanda van der Velden, Roddy Walsh, Petar M. Seferovic, Thomas Thum
Publikováno v:
European journal of heart failure, 24(3), 406-420. Wiley
European Journal of Heart Failure
European Journal of Heart Failure, 2022, 24 (3), pp.406-420. ⟨10.1002/ejhf.2414⟩
de Boer, R A, Heymans, S, Backs, J, Carrier, L, Coats, A J S, Dimmeler, S, Eschenhagen, T, Filippatos, G, Gepstein, L, Hulot, J-S, Knöll, R, Kupatt, C, Linke, W A, Seidman, C E, Tocchetti, C G, van der Velden, J, Walsh, R, Seferovic, P M & Thum, T 2022, ' Targeted therapies in genetic dilated and hypertrophic cardiomyopathies : from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC) ', European Journal of Heart Failure, vol. 24, no. 3, pp. 406-420 . https://doi.org/10.1002/ejhf.2414
European journal of heart failure, 24(3), 406-420. Wiley-Blackwell
European Journal of Heart Failure, 24(3), 406-420. Wiley
European Journal of Heart Failure, 24(3), 406-420. Wiley-Blackwell
European Journal of Heart Failure
European Journal of Heart Failure, 2022, 24 (3), pp.406-420. ⟨10.1002/ejhf.2414⟩
de Boer, R A, Heymans, S, Backs, J, Carrier, L, Coats, A J S, Dimmeler, S, Eschenhagen, T, Filippatos, G, Gepstein, L, Hulot, J-S, Knöll, R, Kupatt, C, Linke, W A, Seidman, C E, Tocchetti, C G, van der Velden, J, Walsh, R, Seferovic, P M & Thum, T 2022, ' Targeted therapies in genetic dilated and hypertrophic cardiomyopathies : from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC) ', European Journal of Heart Failure, vol. 24, no. 3, pp. 406-420 . https://doi.org/10.1002/ejhf.2414
European journal of heart failure, 24(3), 406-420. Wiley-Blackwell
European Journal of Heart Failure, 24(3), 406-420. Wiley
European Journal of Heart Failure, 24(3), 406-420. Wiley-Blackwell
Genetic cardiomyopathies are disorders of the cardiac muscle, most often explained by pathogenic mutations in genes encoding sarcomere, cytoskeleton, or ion channel proteins. Clinical phenotypes such as heart failure and arrhythmia are classically tr
Publikováno v:
Nature Reviews Cardiology. 19:151-167
Hypertrophic cardiomyopathy (HCM) was traditionally described as an autosomal dominant Mendelian disease but is now increasingly recognized as having a complex genetic aetiology. Although eight core genes encoding sarcomeric proteins account for >90%